IE35421B1 - Quinoxaline derivatives - Google Patents

Quinoxaline derivatives

Info

Publication number
IE35421B1
IE35421B1 IE848/71A IE84871A IE35421B1 IE 35421 B1 IE35421 B1 IE 35421B1 IE 848/71 A IE848/71 A IE 848/71A IE 84871 A IE84871 A IE 84871A IE 35421 B1 IE35421 B1 IE 35421B1
Authority
IE
Ireland
Prior art keywords
together signify
taken together
june
alkyl
optionally substituted
Prior art date
Application number
IE848/71A
Other versions
IE35421L (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE35421L publication Critical patent/IE35421L/en
Publication of IE35421B1 publication Critical patent/IE35421B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1351342 Quinoxaline derivatives CIBAGEIGY AG 30 June 1971 [6 July 1970 4 June 1971] 30691/71 Heading C2C Novel compounds (I) (including salts, optical isomers and racemates thereof) where R 1 and R 2 are H, alkyl, alkoxy, halogen, CF 3 or NO 2 or taken together signify alkylenedioxy, R 3 and R 4 are optionally substituted amidino, a monovalent or taken together signify a divalent optionally substituted hydrocarbon or acyl residue separating the sulphur atoms by at most 4 carbons or R 3 and R 4 together signify a direct bond, R 5 and R 6 are H or alkyl or taken together signify -(CH 2 ) n - where n is 1 to 8, are made by standard methods, especially utilizing the corresponding 2,3-bis-(bromomethyl or -mercaptomethyl) - quinoxalines; eyelizations are also utilized. Pharmaceutical preparations especially active against viruses contain (I) as active ingredient; administration may be enterally, parenterally or topically. [GB1351342A]
IE848/71A 1970-07-06 1971-07-02 Quinoxaline derivatives IE35421B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1015970 1970-07-06
CH820271 1971-06-04

Publications (2)

Publication Number Publication Date
IE35421L IE35421L (en) 1971-12-06
IE35421B1 true IE35421B1 (en) 1976-02-04

Family

ID=25702964

Family Applications (1)

Application Number Title Priority Date Filing Date
IE848/71A IE35421B1 (en) 1970-07-06 1971-07-02 Quinoxaline derivatives

Country Status (11)

Country Link
AT (2) AT312624B (en)
AU (1) AU3087571A (en)
BE (1) BE769491A (en)
DE (1) DE2132175A1 (en)
ES (1) ES392918A1 (en)
FR (1) FR2100864B1 (en)
GB (1) GB1351342A (en)
HU (1) HU165503B (en)
IE (1) IE35421B1 (en)
IL (1) IL37213A0 (en)
NL (1) NL7109266A (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE612972A (en) * 1958-07-10 1900-01-01
US3507870A (en) * 1968-12-18 1970-04-21 Pfizer & Co C 1,4-disubstituted-1,2,3,4-tetrahydrophenazine-5,10-dioxides

Also Published As

Publication number Publication date
HU165503B (en) 1974-09-28
BE769491A (en) 1972-01-05
AT312624B (en) 1974-01-10
DE2132175A1 (en) 1972-01-13
FR2100864B1 (en) 1974-09-06
IE35421L (en) 1971-12-06
GB1351342A (en) 1974-04-24
FR2100864A1 (en) 1972-03-24
AU3087571A (en) 1973-01-17
IL37213A0 (en) 1971-10-20
ES392918A1 (en) 1974-07-01
NL7109266A (en) 1972-01-10
AT317228B (en) 1974-08-26

Similar Documents

Publication Publication Date Title
GB1203691A (en) New disubstituted n-amino indoline derivatives and process for preparing them
GB1285016A (en) 3,4-dihydroisoquinoline derivatives
FR2430418A1 (en) HALOGENOMETHYL DERIVATIVES OF A-AMINO ACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
GB1148586A (en) Improvements in or relating to anguidine derivatives
FR2397385A1 (en) RESORCINOL DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
IE35421B1 (en) Quinoxaline derivatives
FR2442226A1 (en) SUBSTITUTED ANILINES, THEIR PREPARATION AND THEIR USES
GB1363658A (en) Benzobicycloalkane compounds
GB1256723A (en)
GB1242160A (en) Isoquinolines
FR2381030A1 (en) 2-PHENYLAMINOMETHYL IMIDAZOLINES AND THEIR PREPARATION
FR2375223A1 (en) 1,2,6-THIADIAZINONES, THEIR PREPARATION AND THEIR USES
FR2401922A1 (en) 4-HYDROXY-ISOPHTHALIC ACID SUBSTITUTE PICOLYLAMIDES, THEIR PREPARATION AND THERAPEUTIC USES
FR2372792A1 (en) AMINOALCOXYBENZENES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2433516A1 (en) PYRIDOXINS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2391189A1 (en) 2-AMINOTETRALINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2361393A1 (en) (2-AZABICYCLO (2.2.2) OCTANE-2-YL) DIPHENYLALCANONES AND DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES, ESPECIALLY AS ANTI-DIARRHEA
FR2433553A1 (en) RESINS OF UNSATURATED POLYESTERS, NOT INHIBITED BY AIR OXYGEN, THEIR PREPARATION AND THEIR USES
GB1315355A (en) Benzotriazole derivatives
FR2395989A1 (en) DIPHENYL DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2390435A1 (en) THIOBENZYLPYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
GB1353511A (en) Sulphamoylpyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity
IE35223L (en) Bis-basic ethers of 2, 6- and 2, 7-dihydroxy-anthraquinones
GB1342643A (en) Thioacetanilide derivatives
GB1298057A (en) Bis(aminoalkylsulphamoyl)anthraquinones